Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat Estrogen Receptor beta ELISA Kit (AC2812)
Cat.#: ASET-1401
Specifications
Description Rat Estrogen Receptor beta ELISA Kit allows for the in vitro quantitative determination of rat Estrogen Receptor beta concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1366 Rat Nestin ELISA Kit (AC2777) Quantitative inquiry ASET-1620 Human SOX2 ELISA Kit (AC3031) Quantitative inquiry ASET-1293 Rat Prokineticin Receptor 1 ELISA Kit (AC2704) Quantitative inquiry ASET-1741 Human eNOS ELISA Kit (AC3152) Quantitative inquiry ASET-1662 Rat TIMP1 ELISA Kit (AC3073) Quantitative inquiry ASET-1240 Human Reelin ELISA Kit (AC2651) Quantitative inquiry ASET-2264 Human Notch1 ELISA Kit (AC3675) Quantitative inquiry ASET-1701 Rat CACNA1A ELISA Kit (AC3112) Quantitative inquiry ASET-1994 Human NDUFS7 ELISA Kit (AC3405) Quantitative inquiry ASET-2195 Human PTPRS ELISA Kit (AC3606) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket